CoChat

Does Adherence to Medications for Type 2 Diabetes Differ Between Individuals With Vs Without Schizophrenia?

Open access
Kreyenbuhl, J., Dixon, L. B., McCarthy, J. F., Soliman, S., Ignacio, R. V., Valenstein, M. · 2010 · Schizophrenia Bulletin
Cited by 99

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Individuals with schizophrenia are at increased risk for poor health outcomes and mortality. This may be due to inadequate self-management of co-occurring conditions, such as type 2 diabetes. We compared adherence to oral hypoglycemic medications for diabetes patients with vs without comorbid schizophrenia. Using Veterans Affairs (VA) health system administrative data, we identified all patients with both schizophrenia and type 2 diabetes and with at least one oral hypoglycemic prescription fill in fiscal year 2002 (N = 11 454) and a comparison group of patients with diabetes who were not diagnosed with schizophrenia (N = 10 560). Nonadherence was operationalized as having a medication possession ratio indicating receipt of less than 80% of needed hypoglycemic medications. Poor adherence was less prevalent among diabetes patients with (43%) than without schizophrenia (52%, P < .001). In multivariable analyses, having schizophrenia was associated with a 25% lower likelihood of poor adherence compared with not having schizophrenia (adjusted odds ratio: 0.75, 95% confidence interval: 0.70-0.80). Poorer adherence was associated with black race, homelessness, depression, substance use disorder, and medical comorbidity. Having more outpatient visits, a higher proportion of prescriptions delivered by mail, lower prescription copayments, and more complex medication regimens were each associated with increased adherence. Among veterans with diabetes receiving ongoing VA care, overall hypoglycemic medication adherence was low, but individuals with comorbid schizophrenia were more likely to be adherent to these medications. Future studies should investigate whether factors such as comanagement of a chronic psychiatric illness or regular contact with mental health providers bestow benefits for diabetes self-management in persons with schizophrenia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/schbul/sbn106

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Research works printed but not linked: 29

  1. Rozenfeld, 2008, The American journal of managed care, 14, 71
  2. Lawrence, 2006, Journal of managed care pharmacy : JMCP, 12, 466, 10.18553/jmcp.2006.12.6.466 · DOI · Paper page
  3. 2004, The Annals of Pharmacotherapy, 38, 1357, 10.1345/aph.1D612 · DOI · Paper page
  4. Pladevall, 2004, Diabetes Care, 27, 2800, 10.2337/diacare.27.12.2800 · DOI · Paper page
  5. Lau, 2004, Diabetes Care, 27, 2149, 10.2337/diacare.27.9.2149 · DOI · Paper page
  6. Hepke, 2004, The American journal of managed care, 10, 144
  7. Citrome, 2006, Psychiatric Services, 57, 1132, 10.1176/appi.ps.57.8.1132 · DOI
  8. 2006, Preventing chronic disease [electronic resource], 3, 1
  9. McCreadie, 2003, The British Journal of Psychiatry, 183, 534, 10.1192/bjp.183.6.534 · DOI · Paper page
  10. Valenstein, 2004, Schizophrenia Bulletin, 30, 255, 10.1093/oxfordjournals.schbul.a007076 · DOI · Paper page
  11. Valenstein, 2002, Medical care, 40, 630, 10.1097/00005650-200208000-00002 · DOI · Paper page
  12. Dolder, 2003, Psychosomatic Medicine, 65, 156, 10.1097/01.PSY.0000040951.22044.59 · DOI · Paper page
  13. Piette, 2007, Psychiatric Services, 58, 207, 10.1176/appi.ps.58.2.207 · DOI · Paper page
  14. 2005, 46, 135
  15. Miller, 2004, Diabetes Care, 27, B10, 10.2337/diacare.27.suppl_2.B10 · DOI · Paper page
  16. McCarthy, 2007, Administration and policy in mental health, 34, 448, 10.1007/s10488-007-0130-2 · DOI
  17. Charlson, 1987, Journal of chronic diseases, 40, 373, 10.1016/0021-9681(87)90171-8 · DOI · Paper page
  18. Whyte, 2007, Diabetic medicine : a journal of the British Diabetic Association, 24, 1442, 10.1111/j.1464-5491.2007.02324.x · DOI
  19. Goldberg, 2007, Psychiatric Services, 58, 536, 10.1176/appi.ps.58.4.536 · DOI
  20. Krein, 2006, Psychiatric Services, 57, 1016, 10.1176/appi.ps.57.7.1016 · DOI · Paper page
  21. Weiss, 2006, Psychiatric Services, 57, 1145, 10.1176/appi.ps.57.8.1145 · DOI · Paper page
  22. Dixon, 2004, Psychiatric Services, 55, 892, 10.1176/appi.ps.55.8.892 · DOI · Paper page
  23. Desai, 2002, American Journal of Psychiatry, 159, 1584, 10.1176/appi.ajp.159.9.1584 · DOI · Paper page
  24. Laurent, 2005, CNS drugs, 19, 1, 10.2165/00023210-200519010-00001 · DOI · Paper page
  25. Dixon, 2007, Psychiatric Services, 58, 600, 10.1176/appi.ps.58.5.600 · doi:10.1176/appi.ps.58.5.600
  26. Rogers, 2004, The Journal of ambulatory care management, 27, 249, 10.1097/00004479-200407000-00009 · DOI · Paper page
  27. Shen, 2003, Medical Care Research and Review, 60, 253, 10.1177/1077558703060002007 · DOI · Paper page
  28. 2008, 49, 123
  29. Andrade, 2006, Pharmacoepidemiology and drug safety, 15, 565, 10.1002/pds.1230 · DOI · Paper page

Cited by

See all 99

Metadata

Authors
Kreyenbuhl, J., Dixon, L. B., McCarthy, J. F., Soliman, S., Ignacio, R. V., & Valenstein, M.
Venue
Schizophrenia Bulletin
Published
2008-08-20
Volume
36
Issue
2
Pages
428-435
ISSN
  • 0586-7614 (ISSN-L)
  • 1745-1701
OpenAlex
W2107746160
Cited by
99
References
9
FWCI
3.92
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Does Adherence to Medications for Type 2 Diabetes Differ Between Individuals With Vs Without Schizophrenia? https://app.cochat.ai/papers/10.1093/schbul/sbn106
The paper
Kreyenbuhl, J., Dixon, L. B., McCarthy, J. F., Soliman, S., Ignacio, R. V., & Valenstein, M. (2010). Does Adherence to Medications for Type 2 Diabetes Differ Between Individuals With Vs Without Schizophrenia? Schizophrenia Bulletin. https://doi.org/10.1093/schbul/sbn106

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.